Abstract

The chromatin remodeling complexes alter chromatin structures. They remodel nucleosomes in ATP-dependent manner and have essential roles in DNA damage repair, recombination, replication and transcriptional control. Increasing evidences indicate that subunits of chromatin remodelers are mutated and/or deregulated in a number of human cancers, and how they influence the cancer gene expression program during cancer initiation and progression is becomming clearer. Therefore, chromatin remodeling complexes arose as promising new targets for the treatment of human cancers. In this review, chromatin remodeling complexes, their epigenetic reader domains and available inhibitors are described. The insights into the misregulated chromatin remodelers pathways in human malignancies and the novel approach targeting deregulated chromatin remodelers to improve chemotherapy efficiency are discussed.

Highlights

  • Malignant cell abuses chromatin remodelers in different waysTo meet the demands of growth, cancer cells reprogram their metabolism

  • A nucleosome is a basic unit of DNA packaging in humans, consisting of 146 bp DNA wrapped around a histone octamer

  • The complexity and specificity of chromatin remodeling complexes is achieved by their accessory subunits, that contain additional epigenetic reader domains, RNA binding domains or even form complexes with histone deacethylases (HDAC) and histone methyltransferases (HMT)[2]

Read more

Summary

Malignant cell abuses chromatin remodelers in different ways

To meet the demands of growth, cancer cells reprogram their metabolism. The connection between cancer and chromatin remodelers arose two decades ago, when SNF5 gene, which encodes a member of the chromatinremodelling SWI/SNF complex, was found to be mutated in malignant rhabdoid tumours[4]. Evidence has been accumulating how the deregulated chromatin remodelers can support the uncontrolled growth of the cell

Loss of expression
De Novo mutations in chromatin remodelers
Findings
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.